Stryker introduces Mako Handheld Robotics with the limited market release of Mako RPS

Rhea-AI Summary

Stryker (NYSE: SYK) announced the limited market release of Mako RPS (Robotic Power System) for Total Knee, introducing Mako Handheld Robotics as an expansion of the Mako family. Mako RPS integrates an intraoperative planner and a robotically enabled saw compatible with Triathlon Total Knee and Q Guidance System.

The system offers active adjustment technology that guides a surgeon's saw to align with the surgical plan and aims to fit into existing workflows without cutting blocks. Stryker will demonstrate Mako SmartRobotics and Mako Handheld Robotics at AAOS 2026, booth #3339.

Key Figures

Orthopaedic robotics experience: nearly 20 years Procedures performed: over 2 million Countries served: 46 countries +5 more

8 metrics

Orthopaedic robotics experience nearly 20 years Mako orthopaedic robotics track record cited in release

Procedures performed over 2 million Mako procedures across 46 countries globally

Countries served 46 countries Global footprint of Mako procedures

AAOS booth number booth #3339 AAOS 2026 Annual Meeting presence for Mako Handheld Robotics

Current share price $358.29 Pre-news trading price from market context

Price vs 52-week high -11.5% Distance from 52-week high of $404.87

52-week low distance 8.85% Above 52-week low of $329.1608

Market capitalization $138,597,978,508 Pre-news equity value from market context

Market Reality Check

Price: $358.29 Vol: Volume 1,996,220 vs 20-da...

normal vol

$358.29 Last Close

Volume Volume 1,996,220 vs 20-day average 2,126,280 (relative volume 0.94x). normal

Technical Price 358.29 trades below 200-day MA at 374.79, indicating a pre-news downtrend bias.

Peers on Argus

SYK was down 1.14% with mixed peers: BSX -1.41%, MDT -0.09%, EW +0.01%, ZBH +1.9...

SYK was down 1.14% with mixed peers: BSX -1.41%, MDT -0.09%, EW +0.01%, ZBH +1.97%, ABT +0.78%. Moves do not indicate a unified sector trend.

Historical Context

5 past events · Latest: Feb 04 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 04	Dividend declaration	Positive	-0.0%	Quarterly cash dividend of $0.88 per share with 4.8% yearly increase.
Jan 29	Earnings results	Positive	-1.0%	Strong Q4 and full-year 2025 sales growth and margin expansion with 2026 outlook.
Jan 06	Asset divestiture	Neutral	+5.0%	Sale of Cestas spine implant manufacturing facility to VB Spine.
Jan 05	Earnings date set	Neutral	+0.2%	Announcement of date and webcast details for Q4 and full-year 2025 results.
Dec 11	Dividend increase	Positive	-0.2%	Quarterly dividend of $0.88 per share, 4.8% above prior year and quarter.

Pattern Detected

Recent positive corporate updates (dividends, strong earnings) often saw flat-to-negative next-day moves, suggesting muted or contrarian price responses to good news.

Recent Company History

Over the last few months, Stryker announced recurring quarterly dividends of $0.88 per share with a 4.8% year-over-year increase and reported strong 2025 results, including $7.17B in Q4 net sales and $25.12B for the full year with margin expansion. The stock reaction to these positives was slightly negative or flat. An asset sale of the Cestas spine facility to VB Spine coincided with a 5.05% gain. Today’s Mako RPS launch fits into a pattern of ongoing portfolio and technology expansion.

Market Pulse Summary

This announcement highlights Stryker’s expansion of the Mako franchise into a handheld robotics plat...

Analysis

This announcement highlights Stryker’s expansion of the Mako franchise into a handheld robotics platform aimed at Total Knee procedures, leveraging nearly 20 years of orthopaedic robotics experience and over 2 million procedures across 46 countries. In recent months the company has coupled steady dividends and strong 2025 results with portfolio moves like the Cestas facility sale. Investors may watch for adoption metrics, surgeon feedback, and future updates around the broader Mako ecosystem.

Key Terms

handheld robotic system, robotically enabled saw, active adjustment technology

3 terms

handheld robotic system technical

"an intuitive handheld robotic system that combines Stryker's proven robotics"

A handheld robotic system is a compact, powered tool that combines sensors, motors and software to help a person perform precise tasks while the device stays in the operator’s hand. Think of it like a smart power drill that guides and steadies your hand to hit the exact spot every time. Investors care because these systems can make procedures faster, safer and cheaper, create repeat sales for consumables or software updates, and open new markets or reimbursement pathways that drive revenue growth.

robotically enabled saw technical

"features intraoperative planning and a robotically enabled saw with Stryker's patented"

A robotically enabled saw is a surgical cutting tool guided by robotic controls and software to make precise bone cuts during operations. Like a GPS-guided power tool, it helps surgeons follow planned angles and depths more consistently than manual cutting, which can reduce variability, shorten procedure time and improve patient outcomes. Investors care because regulatory approval, clinical adoption and reimbursement determine sales potential, manufacturing costs and liability exposure for companies that make or use the device.

active adjustment technology technical

"saw with Stryker's patented active adjustment technology which responds to a surgeon's"

Active adjustment technology is a system that senses changing conditions and automatically changes a product’s behavior or settings in real time to keep performance optimal — like a thermostat that fine‑tunes heating as the weather shifts. For investors, it signals potential for better efficiency, lower operating costs, faster response to issues, and a competitive edge that can boost revenue or reduce risk compared with passive or manual systems.

AI-generated analysis. Not financial advice.

PORTAGE, Mich., Feb. 9, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the limited market release of Mako RPS (Robotic Power System) for Total Knee, an intuitive handheld robotic system that combines Stryker's proven robotics and power tool legacies and represents Mako's expansion into a new robotics platform. Mako now includes Mako SmartRobotics™ – Stryker's multi-specialty, robotic-arm assisted platform featuring Mako 4 – and Mako Handheld Robotics with Mako RPS, which is designed to reach a new market segment.

Compatible with Stryker's Triathlon^® Total Knee System, Mako RPS for Total Knee offers a solution for surgeons who are interested in the potential benefits of robotic technology and want the familiarity of a manual power tool.

"The Mako brand represents our relentless commitment to advancing orthopaedic patient outcomes through robotics leadership," said Mike Carlin, president of Stryker's Ortho Tech division. "With nearly 20 years of experience in orthopaedic robotics and over 2 million procedures performed across 46 countries globally, Mako has established robotics as a standard of care, and we are thrilled to add Mako RPS to the Mako family."

Mako RPS for Total Knee features intraoperative planning and a robotically enabled saw with Stryker's patented active adjustment technology which responds to a surgeon's hand movements, guiding the saw to stay aligned with the surgical plan. Mako RPS integrates easily into a surgeon's workflow and provides a familiar cutting experience without the use of cutting blocks. Built to work with Stryker's multi-specialty guidance platform, Q Guidance System, Mako RPS joins a comprehensive orthopaedic technologies ecosystem designed to offer versatility to the site of care.

Please visit us at booth #3339 during the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting in New Orleans to learn more about Mako SmartRobotics™ and the new Mako Handheld Robotics platform.

About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Media contact
Stryker
Jenny Braga
Senior Director, External Affairs
jenny.braga@stryker.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/stryker-introduces-mako-handheld-robotics-with-the-limited-market-release-of-mako-rps-302682689.html

SOURCE Stryker

FAQ

What is Mako RPS for Total Knee and why does Stryker (SYK) matter to investors?

Mako RPS is a handheld robotic power system designed for Total Knee procedures, expanding Mako into handheld robotics. According to Stryker, it combines robotic guidance with a familiar power-tool experience and integrates with Triathlon Total Knee and the Q Guidance System, targeting surgeons who prefer manual tool familiarity.

How does Mako RPS integrate with Stryker's existing surgical platforms for SYK shareholders?

Mako RPS is designed to work with Stryker's Q Guidance System and Triathlon Total Knee implant system. According to Stryker, the device joins the Mako ecosystem alongside Mako 4 and aims to offer surgical workflow compatibility without cutting blocks.

When and where will Stryker (SYK) showcase Mako Handheld Robotics to potential buyers?

Stryker will showcase Mako SmartRobotics and Mako Handheld Robotics at AAOS 2026 in New Orleans. According to Stryker, attendees can learn more at booth #3339 during the American Academy of Orthopaedic Surgeons Annual Meeting.

What features of Mako RPS could affect surgical adoption rates relevant to SYK performance?

Mako RPS features intraoperative planning and a robotically enabled saw with active adjustment technology to guide hand movements. According to Stryker, this aims to provide a familiar cutting experience and easier integration into surgeons' existing workflows.

Is Mako RPS compatible with Stryker's Triathlon Total Knee system and what does that mean for SYK?

Yes, Mako RPS is compatible with the Triathlon Total Knee system, enabling use with Stryker's existing implant portfolio. According to Stryker, compatibility helps sites adopt the handheld robotic option while leveraging established implant products and guidance systems.